-+ 0.00%
-+ 0.00%
-+ 0.00%

MILESTONE PHARMACEUTICALS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND ANNOUNCES COST-EFFICIENCY MEASURES DESIGNED TO EXTEND CASH RUNWAY THROUGH AFIB-RVR PHASE 3 DATA

Reuters·11/13/2026 12:08:12

Please log in to view news